Any theoretical combination would likely require substantially reduced doses of both compoundsperhaps 1.2-2.4 mg cagrilintide with 4-8 mg retatrutide as maximum limits, though even these suggestions are purely speculative
Karchoubi F, Afshar Ghotli R, Pahlevani H, Baghban Salehi M
This study aimed to compare the impacts of starting GLP-1-RAs versus dipeptidyl peptidase-4 inhibitors (DPP-4is), like linagliptin (Tradjenta) on the risk of heart attacks, strokes, and death among patients with various autoimmune diseases and type 2 diabetes
GLP-1 GLP-1-1 GLP-1 GLP-1 Wegovy SemaglutideSaxenda Liraglutide 2
Madani H, Asgari S, Naderi GA
Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist, meaning it mimics a hormone naturally produced in your gut